Deakin University has secured an international research coup for Australia.
The University?€™s Vice-Chancellor Professor Sally Walker has joined with Dr Kiran Mazumdar-Shaw, head of Biocon, India?€™s largest biotechnology company to sign a Memorandum of Understanding that will bring the two institutions together to work on a number of projects.
These include innovative plans to establish a mammalian cell bio-processing facility at the Geelong Technology Precinct (GTP) which is on Deakin University?€™s Geelong Campus at Waurn Pounds in Victoria. In India, the partnership will facilitate the establishment of a Deakin Research Institute in Bangalore. This will also involve collaborative research with Biocon.
The Institute will have a focus on discovery and applied science in research areas including drug development, biotechnology, new materials and intelligent systems.
An important part of the Indian Institute?€™s work will be research training in India to meet the demands of one of the world?€™s fastest growing economies.
The benefits for young Australian scientists will be greater exposure to working with and meeting the needs of industry, something at which Deakin is already among the leading universities in the country.
The Institute?€™s facilities will include space for ?€˜proof of concept?€™ work based on the successful Deakin University approach to science and technology at the GTP.
?€œThis is a significant move for Deakin University, providing first class links with a leading international company in key areas of research interest including biotechnology, metabolic disease research and wine science,?€